LDN Social Media
Get connected with us on social networks
Erythromelalgia in a Patient with Mast Cell Activation Syndrome: Response to Low Dose Naltrexone
Skin
08 May 2019
https://jofskin.org/index.php/skin/article/view/722
Erythromelalgia is a rare condition that may be associated with a variety of underlying conditions and is often refractory to therapy. We report a case of a patient with mast cell activation syndrome who developed erythromelalgia and responded to low dose naltrexone.
Keywords: erythromelalgia, mast cells, mast cell activation syndrome, MCAS naltrexone, low dose naltrexone